Ramnik Xavier insider trades

Open-market stock purchases and sales by Ramnik Xavier, Director at MoonLake Immunotherapeutics, from SEC Form 4 filings since Apr 6, 2022.

Recent trades

DateStockTradeValue
Jun 17, 2026MLTX MoonLake ImmunotherapeuticsBought (not open market)—

Companies traded

  • MLTX MoonLake Immunotherapeutics: other filings, last Jun 17, 2026

Get free alerts when Ramnik Xavier files a new trade →